GAMMA Investing’s Lexeo Therapeutics LXEO Stock Holding History

GAMMA Investing’s Portfolio LXEO Stock Details LXEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15K	Sell	247 -84	-25%	-$454	﹤0.01%	3852
2026 Q1	$1.9K	Buy	331 +281	+562%	+$1.99K	﹤0.01%	3680
2025 Q4	$497	Buy	+50	New	+$456	﹤0.01%	3914
2025 Q1	–	Sell	-245	Closed	-$1.61K	–	3843
2024 Q4	$1.61K	Buy	+245	New	+$1.93K	﹤0.01%	3287
2024 Q3	–	Sell	-14	Closed	-$225	–	3626
2024 Q2	$225	Buy	+14	New	+$203	﹤0.01%	3310

Other funds holding LXEO

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

KFI

Key Financial Inc West Chester, Pennsylvania $611M AUM 21.11% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's LXEO Position: Q2 2026 in Review

GAMMA Investing reduced its Lexeo Therapeutics (LXEO) stake by 25% in Q2 2026, selling an estimated $454 and leaving 247 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #3852.

GAMMA Investing first reported a position in LXEO in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.9K in Q1 2026. 16 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

GAMMA Investing held 247 shares of Lexeo Therapeutics worth $1.15K as of Q2 2026.
GAMMA Investing sold 84 Lexeo Therapeutics shares in Q2 2026, an estimated $454.
Lexeo Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3852 holding.
GAMMA Investing first reported a position in Lexeo Therapeutics in Q2 2024 and has held it in 5 quarters since.
GAMMA Investing's Lexeo Therapeutics position peaked at $1.9K in Q1 2026.
16 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.